# LATANOPROSTENE BUNOD
> **ANDA217387** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-04-29
## Drug
- **FDA Application Number:** ANDA217387
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LATANOPROSTENE BUNOD
- **Generic name:** LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%
- **Active ingredients:** LATANOPROSTENE BUNOD
- **Dosage form:** SOLUTION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Gland Pharma Limited
- **First approval:** 2025-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217387)
---
*MORVS · CC0 1.0*